CFD RESEARCH CORPORATION - FDABAA-22-00123 - PMQWP 374 - A CFD-PBPK FRAMEWORK FOR SUPPORTING BIOEQUIVALENCE EVALUATION OF OPHTHALMIC DRUGS

PIID: 75F40123C00072Solicitation ID: FDABAA-23-00123

Signed Date: Dec 29, 2025Effective Date: Jun 12, 2023End Date: Closes in 203 days

Award $

$765K

Vendor

CFD RESEARCH CORPORATION

NAICS

541690

Signed Date

Dec 29, 2025

Key Details

Dollars Obligated

$764,916

Base & All Options

Awarding Agency

Department of Health and Human Services

Awarding Sub-Agency

Food and Drug Administration

NAICS Code

541690 - OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES

Product Service Code

B529 - SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

HUNTSVILLE, AL, 358062900, CD-AL-05

Description

FDABAA-22-00123 - PMQWP 374 - A CFD-PBPK FRAMEWORK FOR SUPPORTING BIOEQUIVALENCE EVALUATION OF OPHTHALMIC DRUGS

Context & Analysis

On Dec 29, 2025, Department of Health and Human Services obligated $764,916 to CFD RESEARCH CORPORATION for fdabaa-22-00123 - pmqwp 374 - a cfd-pbpk framework for supporting bioequivalence evaluation of ophthalmic drugs. The award is classified under NAICS 541690 — OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in HUNTSVILLE, AL. The contract is scheduled through Dec 31, 2026 — approximately 7 months remaining.